Thryve, providers of high quality microbiotics and microbiome testing, announced today it has secured $1.4 million in funding. Participating investment firms include PivotNorth Capital, Unilever Ventures, Darling Ventures, Candela Paramount, Abstract Ventures and Joyance Partners. […]
Chr. Hansen completed a clinical trial1 using a carefully selected probiotic strain. Reaching both the primary and secondary end points of the trial, the results show a robust protective effect against gastrointestinal (GI) side effects […]
Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company applying synthetic biology to probiotics to develop novel, living medicines, today announced that Aoife Brennan, M.B., B.Ch., has accepted the position of Interim President and Chief Executive […]
Evelo Biosciences, Inc. (Nasdaq:EVLO) (“Evelo”) today announced the pricing of its initial public offering of 5,312,500 shares of common stock at a public offering price of $16.00 per share, before underwriting discounts and commissions. In […]
Lodo Therapeutics Corporation, a drug discovery and development company focused on identifying and producing unique, bioactive natural products directly from the microbial DNA sequence information contained in soil, today announced that it has formed a […]
Here is the summary of the patent submitted: The present invention is based on the inventors’ surprising discovery that certain bacterial strains showed enhanced in vitro adhesion to one or more of the ABO biood […]
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics, has today announced that the Company has submitted, and the U.S. Food and Drug Administration (FDA) has cleared, an Investigational New […]
Adare Pharmaceuticals, Inc., today announced changes to its Leadership Team to support the next phase of its growth strategy. Since its creation in 2015, the Company has been committed to becoming a global specialty pharmaceutical […]
UAS Laboratories LLC (Wausau, Wisconsin, USA), is celebrating a significant milestone with the opening of their new fermentation facility, located in Madison, Wisconsin, USA. This expansion is the result of a 60-million-dollar investment made to […]
Jennewein Biotechnologie is a leading producer of complex oligosaccharides, focusing on human milk oligosaccharides (HMOs). In July 2018, Jennewein Biotechnologie will launch its first clinical trial of an infant formula containing the five most abundant […]
CosmosID is the recipient of the 2018 Technology Idol award presented at the recent Global Water Summit held in Paris, France. This prestigious prize is awarded annually by a panel of judges to a new […]